TRIUMPH trial: Eli Lilly's Phase 3 clinical trial program evaluating retatrutide in obesity and related indications
Key facts about GLP-1-related gastroparesis: How it happens: GLP-1 drugs slow gastric emptying as part of their mechanism, but this effect becomes excessive in some people Whos at risk: Those with pre-existing digestive disorders, prior gastric surgery, long-standing diabetes, or elderly patients face higher risk Timeline: Symptoms can appear at any point during treatment, especially during dose increases Reversibility: Most cases improve after dose reduction or medication discontinuation, with recovery taking days to several months Management options: Dietary changes (smaller, low-fat meals), slower dose escalation, supportive medications, or temporary drug cessation Seek immediate medical attention for severe vomiting, dehydration signs, intense abdominal pain, or blood in vomit or stool
Frequently Asked Questions Can I take semaglutide while exclusively breastfeeding
The good news is that, generally speaking, taking Mounjaro or other GLP-1 medications like Ozempic (semaglutide) and Wegovy (semaglutide) is not typically a disqualifying factor for plasma donation
Moreover, the MD may confer targeted advantages for women with female-specific conditions such as polycystic ovary syndrome, pregnancy-related complications, and autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus [108]
When it comes to important brain regions modulating this, there is some overlap as well as differences between the three peptides
